Stanford University: Hodgkin Disease trials
The registry lists 10 Hodgkin Disease studies with Stanford University as lead sponsor. 1 are open to participants now and 3 have results posted.
Phase 1 1Phase 2 5No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's DiseaseRecruitingNCT00398177
- Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's DiseaseCompletedNCT00388349Phase 2Results posted
- Allogeneic Transplantation From Related Haploidentical DonorsCompletedNCT00185692Phase 2Results posted
- Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's LymphomaCompletedNCT00026208Phase 2Results posted
- Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse EventsCompletedNCT05123001
- Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCTTerminatedNCT02728700Phase 1
- Consent for Obtaining Additional Tissue at the Time of a Diagnostic BiopsyCompletedNCT01078350
- Combination Chemotherapy +/- Radiation in High Risk Hodgkin's DiseaseTerminatedNCT00225173Phase 2
- High Dose Chemotherapy Followed By PBSC Rescue for HDCompletedNCT00186251Not applicable
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's DiseaseCompletedNCT00002714Phase 2